193 | These a | judith keenan | 10/26/2012 12:38:09 PM |
192 | I'm exp | judith keenan | 10/26/2012 12:36:00 PM |
191 | PTSH is | judith keenan | 10/26/2012 12:33:35 PM |
190 | $29BN INDUSTRY | Milly Joel | 10/26/2012 12:32:33 PM |
189 | GROWTH | Milly Joel | 10/26/2012 12:31:22 PM |
188 | PTSH is | judith keenan | 10/26/2012 12:31:06 PM |
187 | Just a part of the game PTSH | judith keenan | 10/26/2012 12:29:13 PM |
186 | DEMAND | Milly Joel | 10/26/2012 12:27:41 PM |
185 | When th | aleksdavis | 10/26/2012 11:15:33 AM |
184 | If not | aleksdavis | 10/26/2012 11:03:38 AM |
183 | Now is | aleksdavis | 10/26/2012 10:47:47 AM |
182 | Perfect | Mary Johnson | 10/26/2012 10:36:24 AM |
181 | You are | Mary Johnson | 10/26/2012 10:31:23 AM |
180 | PTSH Almost there! | John Howard | 10/26/2012 10:29:32 AM |
179 | Everyth | John Howard | 10/26/2012 10:25:08 AM |
178 | Looking | aleksdavis | 10/26/2012 10:23:22 AM |
177 | PTSH ha | John Howard | 10/26/2012 10:22:34 AM |
176 | Take lo | John Howard | 10/26/2012 10:20:02 AM |
175 | Amazing | aleksdavis | 10/26/2012 10:19:20 AM |
174 | ALERT:Intermediate Term Bullish Breakout PTSH | Mary Johnson | 10/26/2012 10:14:46 AM |
173 | So many | aleksdavis | 10/26/2012 10:13:20 AM |
172 | PTSH since 10/12/12 Since | John Howard | 10/26/2012 10:11:29 AM |
171 | I believe that PTSH will close green.Everything | Mary Johnson | 10/26/2012 10:05:31 AM |
170 | Amazing | Mary Johnson | 10/26/2012 9:53:12 AM |
169 | This wa | aleksdavis | 10/26/2012 9:52:06 AM |
168 | Guide for players Short run players: | Mary Johnson | 10/26/2012 9:48:52 AM |
167 | 7-day retrospective Since October 19th, | aleksdavis | 10/26/2012 9:48:02 AM |
166 | Predictions for 2day?Hi guys I have to remind you | Mary Johnson | 10/26/2012 9:40:46 AM |
165 | I'd lov | theellasmith | 10/26/2012 6:37:03 AM |
164 | Well th | mwirmm | 10/26/2012 6:32:52 AM |
163 | UW&E is a company with loads of potential to | theellasmith | 10/26/2012 6:17:06 AM |
162 | UW&E OUTLOOK Lots of perspective here, I | mwirmm | 10/26/2012 6:13:23 AM |
161 | Exactly | mwirmm | 10/26/2012 6:04:55 AM |
160 | Yeh I f | mwirmm | 10/26/2012 6:03:22 AM |
159 | Yeh ive | mwirmm | 10/26/2012 6:02:33 AM |
158 | theellasmith | 10/26/2012 5:22:35 AM | |
157 | I think | mwirmm | 10/26/2012 5:20:39 AM |
156 | PTSH an | theellasmith | 10/26/2012 4:51:35 AM |
155 | You're | theellasmith | 10/26/2012 4:46:15 AM |
154 | Well i | mwirmm | 10/26/2012 4:44:06 AM |
153 | Well it | mwirmm | 10/26/2012 4:42:52 AM |
152 | PTSH - today | theellasmith | 10/26/2012 4:04:38 AM |
151 | PTSH - long term! EMA indicator is | theellasmith | 10/26/2012 4:00:50 AM |
150 | PTSH - a chance | theellasmith | 10/26/2012 3:55:33 AM |
149 | You are | Mary Johnson | 10/25/2012 2:52:55 PM |
148 | Storm trading week | Mary Johnson | 10/25/2012 2:44:04 PM |
147 | Well th | Mary Johnson | 10/25/2012 1:18:56 PM |
146 | Everyth | John Howard | 10/25/2012 11:10:44 AM |
145 | PTSH looking good short term also.. | John Howard | 10/25/2012 11:04:38 AM |
144 | Next bo | John Howard | 10/25/2012 11:00:54 AM |
Recent Articles
- New Forever Stamp Celebrates Legacy of Former President Carter
- XPPen Marks 20 Years of Innovation and Creativity in Art
- Investigation Launched for Investors of GSK plc Amid Concerns
- Unraveling Investor Concerns Involving Confluent, Inc. Stock
- Investigation into Neogen Corporation Raises Concerns for Investors
- Class Action Filed Against Alto Neuroscience Over IPO Misrepresentation
- Class Action Lawsuit Announced Against Hims & Hers Health, Inc.
- Understanding the Legal Landscape for PetMed Investors
- Class Action Filed Against Flywire Corporation: A Legal Overview
- Investigation into Unicycive Therapeutics Raises Consumer Concerns
- Join the Class Action Against XPLR Infrastructure: Your Rights Matter
- Dyne Therapeutics Faces Investigations Over Alleged Fraud Claims
- iRobot Faces Class Action Lawsuit as Investor Confidence Wanes
- Ricardo Salinas Plans Full Bitcoin Investment Strategy
- Investigation Announced for Geely Automobile Holdings Investors
- Capricor Therapeutics Faces Investigation Amid Stock Concerns
- Important Updates for Investors in Fiserv, Inc. Lawsuit
- Investors Alerted: Class Action Lawsuit Against RxSight, Inc.
- Reddit Faces Legal Action Amidst Declining User Rates
- Major Class Action Opportunity for Charter Communications Investors
- Understanding the Replimune Group Class Action Lawsuit Process
- Trump and Putin: A Controversial Conversation on Election Integrity
- Investors Alert: Class Action Filed Against Biohaven Ltd.
- Investigation into Barnes & Noble Education Sparks Concern
- Simulations Plus Faces Scrutiny Amidst Financial Challenges
- Tesla Faces Class Action Lawsuit Amidst Controversial Robotaxi Launch
- Exploring Legal Investigations into Dow Inc. for Investors
- Investigation into Tronox Holdings: Examining Recent Developments
- Albany International Corp. Faces Investor Scrutiny Amid Concerns
- Inspire Medical Systems on the Radar as Stock Drops Significantly
- Spectrum Pharmaceuticals Faces Class Action Lawsuit Reminder
- Lockheed Martin Faces Class Action Amidst Losses and Lawsuit
- Mohamed bin Zayed University Welcomes Record Student Cohort
- What is Ethereum? A Simple Guide for New Crypto Users
- Investigation into Altimmune, Inc. Potential Securities Violations
- American Outdoor Brands: Investigating Claims For Investors
- Investigation into BellRing Brands, Inc. Raises Concerns for Investors
- Investor Insights: Harrow Inc. Investigated for Securities Fraud
- Investigation into Funko, Inc. by Pomerantz Law Firm
- Investors Urged to Learn About Mereo BioPharma's Situation
- Investigation into Charter Communications Raises Concerns
- Investor Concerns Grow for Anika Therapeutics Amid Legal Scrutiny
- Understanding the Recent Class Action Against Novo Nordisk
- Legal Investigation of Zeekr Intelligent Technology Holding
- Investor Advocacy: Understanding Telix Pharmaceuticals' Recent Events
- Exelixis Faces Investor Scrutiny Amid Financial Reporting Concerns
- Investigation Into NeoGenomics, Inc. Sparks Legal Interest
- Understanding WPP plc's Recent Challenges and Investigations
- Praxis Precision Medicines Faces Securities Investigation Insights
- Insights Into Insperity's Recent Performance and Investor Actions